Product Images Bortezomib

This is a graph displaying the proportion of patients who received Bortezomib over time (in days) compared to the proportion of patients who received Doxamethasone. The p-value from the log-rank test is less than 0.00017, indicating a statistically significant difference between the two groups. The number of patients remaining at each time point is also given.*

This text represents the proportion of patients receiving Bortezomib and Dexamethasone at different time points. There is a statistical significance between the two treatments represented by a p-value obtained through a log-rank test. However, further information is not available to provide more context.*

This appears to be a table representing different subjects and their performance over time. The subjects are labeled as "VeR-CAP" and "RCHOP" and the performance is measured based on the month. The table seems to have columns displaying the months and percentage values. A detailed analysis is difficult without a better understanding of the source material.*

This is a graph that shows the survival rate of subjects enrolled in a clinical trial for two treatments named VGR-CAP and R-CHOP. The Hazard Ratio value is also provided. It is not possible to determine the type of clinical trial, medical condition or treatment details as the text contains limited information.*